Biosimilar Insulins Satisfy EMA’s CHMP

NovoMix And Actrapid Rivals From Sanofi And Baxter Endorsed By Agency

The EMA’s CHMP has issued positive opinions for two insulin biosimilars: Sanofi’s insulin aspart rival to NovoMix and Baxter’s insulin human (rDNA) version of Actrapid. At the same time, the CHMP has confirmed its recommendation to refuse marketing authorization for the Ipique ophthalmic version of bevacizumab.

EU flag Europe thumbs up
Sanofi and Baxter have received European insulin nods • Source: YAY Media AS / Alamy Stock Photo

Two insulin biosimilars, Sanofi’s Truvelog Mix 30 rival to NovoMix (insulin aspart) and Baxter’s Inpremzia version of Actrapid (insulin human rDNA) have been granted positive opinions recommending pan-European marketing authorizations by the committee for medicinal products for human use within the European Medicines Agency.

Truvelog Mix 30 will be available as a 100U/ml suspension for injection while Inpremzia will be available as 1IU/ml solution...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.